Introduction Involvement of European Tuberous Sclerosis Complex Patient Organisations (E-TSC) establishing an European registry of patients living with Tuberous sclerosis complex (TSC) to address some gaps in understanding the...
Background/Rationale for the document This tool provides recommendations on the competencies (understood as knowledge, skills and behaviours) and resources that each stakeholder organisation should aspire to have in place...
1. Introduction Translational medicine also referred to as translational science or translational research, is defined[¹] as an area of biomedical research that aims to improve human health and longevity...
After they are published, clinical study results should be critically reviewed and assessed for such things as reliability, bias, significance, and fit with existing literature.
Transcription My name is Nancy Hamilton. Right now, I am the training manager at EURORDIS, which is the European Organisation for Rare Diseases. I organise what we call...
The starter kits provide you with links to relevant background reading in the toolbox and associated PowerPoint slide decks and media in order to prepare a single or multi-day...
During the non-clinical safety testing step of the medicines discovery and development process, molecules undergo safety testing in animal subjects in order to determine whether or not they are...
Clinical trial results are statistically analysed in terms of demographics, efficacy, and safety. Different types of clinical trial may warrant different interpretations of trial results.
There are several kinds of bias that may occur in clinical trials, including selection, measurement, and publication bias. Statistics are used in clinical trials in order to avoid or...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy
